Jamie Bump
Payments from drug & device makers
Across 87 payments — averaging $19.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$315
- AstraZeneca$306
- Mayne Pharma Commercial LLC$191
- Novo Nordisk$168
- Novartis$131
- Amgen$91
- plus $516 from 17 others
What the payments were for
- Food & beverage$1,718100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 20 | $315 |
| AstraZeneca | 13 | $306 |
| Mayne Pharma Commercial LLC | 1 | $191 |
| Novo Nordisk | 10 | $168 |
| Novartis | 6 | $131 |
| Amgen | 6 | $91 |
| Johnson & Johnson | 4 | $59 |
| Lilly USA, LLC | 4 | $53 |
| Mylan Specialty L.p. | 3 | $49 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $41 |
| Agile Therapeutics, Inc. | 2 | $38 |
| Bayer | 2 | $36 |
| Pfizer | 2 | $35 |
| Dexcom, Inc. | 1 | $34 |
| GSK | 2 | $31 |
| Braeburn Inc. | 1 | $27 |
| Hologic Sales And Service, LLC | 1 | $22 |
| E.r. Squibb & Sons, L.L.C. | 1 | $19 |
| Alvogen Inc | 1 | $17 |
| Viatris Specialty LLC | 1 | $15 |
| Daiichi Sankyo Inc. | 1 | $14 |
| Corium, LLC | 2 | $13 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $13 |
How this compares
$1,718 in reported general payments places this provider in the 80th percentile of 4,941 family providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 59 | $48,798 |
| TrulicityDulaglutide | 36 | $34,623 |
| JanuviaSitagliptin Phosphate | 45 | $34,246 |
| TradjentaLinagliptin | 33 | $27,587 |
| Tresiba Flextouch U-100Insulin Degludec | 43 | $22,031 |
| Breo ElliptaFluticasone/Vilanterol | 45 | $18,458 |
| OzempicSemaglutide | 13 | $16,170 |
| EliquisApixaban | 20 | $14,560 |
| XareltoRivaroxaban | 16 | $12,764 |
| Incruse ElliptaUmeclidinium Bromide | 37 | $12,301 |
| Advair HfaFluticasone Propion/Salmeterol | 23 | $8,159 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 12 | $7,346 |
| FarxigaDapagliflozin Propanediol | 13 | $6,585 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 17 | $5,012 |
| SymbicortBudesonide/Formoterol Fumarate | 21 | $4,608 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKBreo Ellipta, Incruse Ellipta, Trelegy Ellipta | $31 | $38,10594 claims |
| Lilly USA, LLCTrulicity | $53 | $34,62336 claims |
| Novo NordiskOzempic | $168 | $16,17013 claims |
| PfizerEliquis | $35 | $14,56020 claims |
| Johnson & JohnsonXarelto | $59 | $12,76416 claims |
| AstraZenecaFarxiga, Symbicort | $306 | $11,19334 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 4,941 family providers in Illinois.
Other family in Olney
- Ruth CarricoChicago$582K
- Aleksandra BielawiecBarrington$373K
- Erin SieberNaperville$334K
- Jamie BroganChicago$282K
- Ashley NoethGlen Carbon$271K
- Marita KametasChicago$259K
- Shammona ClarkChicago$247K
- Amanda McKeeMount Vernon$242K
- Brooke KennardBloomington$208K
- Amy BrownellElk Grove Village$202K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.